The Technical Analyst
R1 RCM Inc [RCM]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
R1 RCM Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-0.49% $12.15
America/New_York / 17 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5 106.40 mill |
| EPS: | 0.0100 |
| P/E: | 1 215.00 |
| Earnings Date: | Feb 14, 2024 |
| SharesOutstanding: | 420.28 mill |
| Avg Daily Volume: | 3.75 mill |
| RATING 2024-04-17 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 1 215.00 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 1 215.00 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$8.98 (-26.10%) $-3.17 |
| Date: 2024-04-17 |
| Expected Trading Range (DAY) |
|---|
|
$ 11.72 - 12.58 ( +/- 3.56%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-27 | Flanagan Joseph Gerard | Buy | 148 849 | Common Stock |
| 2024-02-27 | Flanagan Joseph Gerard | Sell | 55 825 | Common Stock |
| 2024-03-11 | Sparby John M. | Sell | 3 101 | Common Stock |
| 2024-03-06 | Sparby John M. | Sell | 3 750 | Common Stock |
| 2024-03-07 | Sparby John M. | Sell | 10 046 | Common Stock |
| INSIDER POWER |
|---|
| -60.53 |
| Last 88 transactions |
| Buy: 2 022 016 | Sell: 17 306 828 |
Forecast:
16:00 - $12.16
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $12.16
Forecast 2: 16:00 - $12.16
Forecast 3: 16:00 - $12.16
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $12.15 (-0.49% ) |
| Volume | 1.231 mill |
| Avg. Vol. | 3.75 mill |
| % of Avg. Vol | 32.82 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RCM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $10.54 | N/A | Active |
|---|
RCM
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Latest Press Releases
2024-04-01 17:00:00 - Press Release
R1 Rcm To Release First Quarter 2024 Results On May 8, 2024
Murray, utah, april 01, 2024 (globe newswire) -- r1 rcm inc. (nasdaq: rcm), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended march 31, 2024, before market open on wednesday, may 8, 2024 and host a conference call at 8:00 a.m. et to review the results.
2024-03-27 08:00:00 - Press Release
R1 Releases Fourth Annual Environmental, Social And Governance (esg) Report
Report highlights r1's commitment to corporate responsibility and sustainability across the company's global footprint report highlights r1's commitment to corporate responsibility and sustainability across the company's global footprint
2024-03-01 04:00:00 - Press Release
R1 Rcm Inc. (rcm) Investigation: Bronstein, Gewirtz & Grossman, Llc Encourages Investors To Seek Compensation For Alleged Wrongdoings
New york--(business wire)---- $rcm #classaction--attorney advertising-- bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of r1 rcm inc. (“r1” or “the company”) (nasdaq: rcm). investors who purchased r1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/rcm. investigation details: the investigation concerns whether rcm and its board violated the federal securities laws and/or breached their fid.
2024-02-28 17:27:00 - Press Release
R1 Rcm Inc. (rcm) Investigation: Bronstein, Gewirtz & Grossman, Llc Encourages Investors To Seek Compensation For Alleged Wrongdoings
New york--(business wire)---- $rcm #classaction--attorney advertising--bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of r1 rcm inc. (“r1” or “the company”) (nasdaq: rcm). investors who purchased r1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/rcm. investigation details: the investigation concerns whether rcm and its board violated the federal securities laws and/or breached their fidu.
2024-02-27 07:00:00 - Press Release
R1 Rcm Reports Fourth Quarter And Full Year 2023 Results
Murray, utah, feb. 27, 2024 (globe newswire) -- r1 rcm inc. (nasdaq: rcm) ("r1" or the "company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended december 31, 2023.
Latest News
2024-04-01 17:00:00 - GlobeNewsWire
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results.
2024-03-12 07:31:03 - Zacks Investment Research
New Strong Sell Stocks for March 12th
AMN, RCM and RC have been added to the Zacks Rank #5 (Strong Sell) List on March 12, 2024.
2024-02-27 11:01:14 - Zacks Investment Research
Compared to Estimates, R1 RCM Inc. (RCM) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for R1 RCM Inc. (RCM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-02-27 09:16:06 - Zacks Investment Research
R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q4
R1 RCM Inc. (RCM) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.09 per share a year ago.
2024-02-26 09:31:15 - Zacks Investment Research
Should You Buy R1 RCM (RCM) Ahead of Earnings?
R1 RCM (RCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2024-02-22 10:20:43 - Zacks Investment Research
Ahead of R1 RCM Inc. (RCM) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of R1 RCM Inc. (RCM) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
2024-02-20 11:06:43 - Zacks Investment Research
R1 RCM Inc. (RCM) Reports Next Week: Wall Street Expects Earnings Growth
R1 RCM Inc. (RCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-02-16 17:00:00 - GlobeNewsWire
R1 RCM to Present at Upcoming Investor Conferences
MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences:
2024-02-09 12:40:22 - Zacks Investment Research
TIXT vs. RCM: Which Stock Is the Better Value Option?
Investors with an interest in Technology Services stocks have likely encountered both Telus International (TIXT) and R1 RCM Inc. (RCM). But which of these two stocks offers value investors a better bang for their buck right now?
2023-12-26 13:02:00 - Market Watch
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
When investors think about whether to increase their exposure beyond the big companies that grab most of the headlines in the financial media, they are likely to look at small-cap stocks first. After all, the sky's the limit.